PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
49.84
+0.29 (0.59%)
Jun 27, 2025, 4:00 PM - Market closed
PTC Therapeutics Market Cap
PTC Therapeutics has a market cap or net worth of $3.95 billion as of June 27, 2025. Its market cap has increased by 36.94% in one year.
Market Cap
3.95B
Enterprise Value
4.40B
1-Year Change
36.94%
Ranking
Category
Stock Price
$49.84
Market Cap Chart
Since June 20, 2013, PTC Therapeutics's market cap has increased from $366.20M to $3.95B, an increase of 978.69%. That is a compound annual growth rate of 21.87%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 26, 2025 | 3.93B | 12.81% |
Dec 31, 2024 | 3.48B | 67.39% |
Dec 29, 2023 | 2.08B | -24.20% |
Dec 30, 2022 | 2.74B | -2.56% |
Dec 31, 2021 | 2.82B | -32.38% |
Dec 31, 2020 | 4.16B | 40.68% |
Dec 31, 2019 | 2.96B | 70.95% |
Dec 31, 2018 | 1.73B | 150.23% |
Dec 29, 2017 | 692.00M | 84.83% |
Dec 30, 2016 | 374.40M | -66.28% |
Dec 31, 2015 | 1.11B | -36.17% |
Dec 31, 2014 | 1.74B | 311.45% |
Dec 31, 2013 | 422.80M | 15.46% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 714.10B |
Johnson & Johnson | 366.20B |
AbbVie | 329.06B |
Novo Nordisk | 301.06B |
UnitedHealth Group | 273.46B |
Abbott Laboratories | 232.29B |
Novartis AG | 231.01B |
AstraZeneca | 216.45B |